Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Postoperative Cognitive Function in Geriatric Robotic Urologic Surgery
NCT07047898Not yet recruiting
- Sponsor
- Ankara Etlik City Hospital
- Start
- Aug 2025
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of dexmedetomidine in Post-operative cognitive dysfunction (POCD) (2 arms), sponsored by Ankara Etlik City Hospital. Primary endpoint: Postoperative cognitive dysfunction at 7 days. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT07047898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07047898.